This website uses cookies (our own or those of other websites) to collect data and track navigation informations. If you wish to find out more, or do not consent to the use of all or some cookies, Click here

Ok

News

13/01/2017
ALFASIGMA EXPANDS ITS FOOTPRINT IN THE U.S. THROUGH THE ACQUISITION OF PAMLAB FROM NESTLE HEALTH SCIENCE
17/10/2016
RIFXIMA® obtains Marketing Authorization for Japan
12/06/2015
A new acknowledgement for Alfa Wassermann's Rifaximin: FDA approves Xifaxan® for the treatment of Irritable Bowel Syndrome-D
26/05/2015
Interview with Stefano Golinelli by Margherita Lopes - Adnkronos Salute’s PharmaKronos
18/05/2015
ALFASIGMA IS BORN THE NEW ITALIAN PHARMACEUTICAL ENTITY WITH STRONG INTERNATIONAL PRESENCE
05/03/2015
LAUNCH OF THE INDUSTRIAL PARTNERSHIP IN THE PHARMA BUSINESS BETWEEN ALFA WASSERMANN AND SIGMA-TAU: SETTING UP A LEADING ITALIAN PHARMACEUTICAL GROUP
23/02/2015
Further recognition at the European level for rifaximin-α, the molecule which is the outcome of “Made in Italy” research by Alfa Wassermann
12/06/2014
Milan district court confirms the validity of Alfa Wassermann’s Rifaximin-alpha patents
24/04/2014
2014 Annual Shareholders’ Meeting
05/08/2013
Alfa Wassermann S.p.A. incorporates Promefarm S.r.l.
03/12/2012
Alfa Wassermann S.p.A. acquires Promefarm S.r.l.
05/09/2012
SALIX PHARMACEUTICALS, INC. PRESS RELEASE - Salix Pharmaceuticals Announces License Agreement for a New Extended Intestinal Release Formulation of Rifaximin
27/04/2012
The Consolidated Balance 2011
28/04/2011
The Consolidated Balance 2010
26/03/2010
FDA approves Rifaximin in Hepatic Encephalopathy (HE) treatment
23/02/2010
The FDA Advisory Committee recommends approval of Rifaximin in Hepatic Encephalopathy (HE)
14/12/2009
Rifaximin in the treatment of Irritable Bowel Syndrome (IBS).
15/06/2009
ALFA WASSERMANN, A NEW SCENARIO FOR RIFAXIMIN
27/11/2008
A PHASE III CLINICAL TRIAL HAS DEMONSTRATED THE EFFICACY OF RIFAXIMIN IN THE PREVENTION OF HEPATIC ENCEPHALOPATHY.In
04/06/2008
ITALIAN PHARMACEUTICALS SET TO CONQUER RUSSIA
28/01/2008
The first 60 years of Alfa Wassermann
01/06/2007
Alfa Wassermann with the Teatro Comunale di Bologna (Bologna Municipal Theatre)
30/05/2007
Alfa Wassermann with the Teatro Comunale to celebrate its first 60 years of life
7/10/2005
Industrie in Piazza - Bologna
24/05/2004
FDA APPROVES RIFAXIMIN
27/12/2001
ALFA WASSERMANN ANNOUCES ITS PROPRIETARY PRODUCT RIFAXIMIN NDA SUBMISSION BY SALIX PHARMACEUTICALS